Combination of Brentuximab Vedotin and Pembrolizumab as Salvage Treatment Before Autologous Stem Cell Transplantation and Maintenance in Patients with Relapsed/Refractory Hodgkin Lymphoma.

Auteurs

Massa H, Massaro F, Maerevoet M

  • Date de publication

    Januari 2025

  • Type

    Article

  • Tijdschrift

    Biomedicines

  • Naam van de onderzoeker

    MASSA HANNE

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Médecine Interne

  • PMID

    40002670

  • DOI

    10.3390/biomedicines13020252